The protein biosynthesis inhibitor vioprolide A evokes anti-angiogenic and pro-survival actions by targeting NOP14 and decreasing VEGF receptor 2- and TAZ-signaling.

[1]  Yuqi Luo,et al.  Increased expression of NOP14 is associated with improved prognosis due to immune regulation in colorectal cancer , 2022, BMC Gastroenterology.

[2]  S. Michalakis,et al.  The natural product vioprolide A exerts anti-inflammatory actions through inhibition of its cellular target NOP14 and downregulation of importin-dependent NF-ĸB p65 nuclear translocation. , 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[3]  Liqun He,et al.  Role of Venous Endothelial Cells in Developmental and Pathologic Angiogenesis , 2021, Circulation.

[4]  Yong Huang,et al.  NOP14 regulates the growth, migration, and invasion of colorectal cancer cells by modulating the NRIP1/GSK-3β/β-catenin signaling pathway , 2021, European journal of histochemistry : EJH.

[5]  Cheng-Chang Chen,et al.  TPC2 promotes choroidal angiogenesis and inflammation in a mouse model of neovascular age-related macular degeneration , 2021, Life Science Alliance.

[6]  J. Pais de Barros,et al.  VEGF-R2/Caveolin-1 Pathway of Undifferentiated ARPE-19 Retina Cells: A Potential Target as Anti-VEGF-A Therapy in Wet AMD by Resvega, an Omega-3/Polyphenol Combination , 2021, International journal of molecular sciences.

[7]  S. Palma,et al.  Biological drug therapy for ocular angiogenesis: Anti‐VEGF agents and novel strategies based on nanotechnology , 2021, Pharmacology research & perspectives.

[8]  Junbo Zhou,et al.  BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas , 2021, Cancer biology & medicine.

[9]  X. Zhao,et al.  Integrated analysis of RNA-binding proteins in human colorectal cancer , 2020, World Journal of Surgical Oncology.

[10]  E. Jho,et al.  MAML1/2 promote YAP/TAZ nuclear localization and tumorigenesis , 2020, Proceedings of the National Academy of Sciences.

[11]  Huanming Yang,et al.  Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis. , 2020, Cell metabolism.

[12]  Xiangyi Zheng,et al.  CCND1, NOP14 and DNMT3B are involved in miR‐502‐5p–mediated inhibition of cell migration and proliferation in bladder cancer , 2020, Cell proliferation.

[13]  A. Vollmar,et al.  The Cytotoxic Natural Product Vioprolide A Targets Nucleolar Protein 14, Which Is Essential for Ribosome Biogenesis , 2019, Angewandte Chemie.

[14]  C. Cheung,et al.  Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction , 2019, Front. Pharmacol..

[15]  R. Brandes,et al.  Narciclasine inhibits angiogenic processes by activation of Rho kinase and by downregulation of the VEGF receptor 2. , 2019, Journal of molecular and cellular cardiology.

[16]  Yonggang Zheng,et al.  The Hippo Signaling Pathway in Development and Disease. , 2019, Developmental cell.

[17]  Wenyi Wei,et al.  Hippo signaling is intrinsically regulated during cell cycle progression by APC/CCdh1 , 2019, Proceedings of the National Academy of Sciences.

[18]  W. Hong,et al.  Role of Hippo Pathway-YAP/TAZ Signaling in Angiogenesis , 2019, Front. Cell Dev. Biol..

[19]  P. Zorlutuna,et al.  YAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility , 2019, The Journal of cell biology.

[20]  Jian-Qin Wang,et al.  NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/β-catenin signaling pathway , 2018, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[21]  Dhruv Chauhan,et al.  BAX/BAK-Induced Apoptosis Results in Caspase-8-Dependent IL-1β Maturation in Macrophages. , 2018, Cell reports.

[22]  Leng Han,et al.  Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer , 2018, Cell reports.

[23]  Andreas Fischer,et al.  Human Endothelial Cell Spheroid-based Sprouting Angiogenesis Assay in Collagen. , 2018, Bio-protocol.

[24]  Q. Tu,et al.  Biosynthesis and Heterologous Production of Vioprolides: Rational Biosynthetic Engineering and Unprecedented 4-Methylazetidinecarboxylic Acid Formation. , 2018, Angewandte Chemie.

[25]  A. Strasser,et al.  How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? , 2017, Cell Death and Differentiation.

[26]  E. Hirsch,et al.  Angiogenesis in metabolic-vascular disease , 2017, Thrombosis and Haemostasis.

[27]  T. Jiao,et al.  Pancreatic Cancer Progression Relies upon Mutant p53-Induced Oncogenic Signaling Mediated by NOP14. , 2017, Cancer research.

[28]  A. Toker,et al.  AKT/PKB Signaling: Navigating the Network , 2017, Cell.

[29]  L. DiPietro,et al.  Angiogenesis and wound repair: when enough is enough , 2016, Journal of leukocyte biology.

[30]  Carlos Luzzani,et al.  AKT/GSK3β signaling pathway is critically involved in human pluripotent stem cell survival , 2016, Scientific Reports.

[31]  Rajesh Raju,et al.  VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis , 2016, Journal of Cell Communication and Signaling.

[32]  G. Calaf,et al.  Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines. , 2016, International journal of oncology.

[33]  K. Guan,et al.  YAP and TAZ: a nexus for Hippo signaling and beyond. , 2015, Trends in cell biology.

[34]  Yi-Fan Lian,et al.  NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway , 2015, Oncotarget.

[35]  S. Dupont,et al.  The biology of YAP/TAZ: hippo signaling and beyond. , 2014, Physiological reviews.

[36]  R. Parsons,et al.  PTEN function: the long and the short of it. , 2014, Trends in biochemical sciences.

[37]  Chaoqian Xu,et al.  Doxorubicin Caused Apoptosis of Mesenchymal Stem Cells via p38, JNK and p53 Pathway , 2013, Cellular Physiology and Biochemistry.

[38]  J. Rakic,et al.  Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice , 2013, Nature Protocols.

[39]  Lois E. H. Smith,et al.  Correction: Choroid Sprouting Assay: An Ex Vivo Model of Microvascular Angiogenesis , 2013, PLoS ONE.

[40]  Sang-Mo Kwon,et al.  Angiogenesis and Its Therapeutic Opportunities , 2013, Mediators of inflammation.

[41]  Fei Liu,et al.  Inhibition of Protein Synthesis Alters Protein Degradation through Activation of Protein Kinase B (AKT)* , 2013, The Journal of Biological Chemistry.

[42]  R. Sachidanandam,et al.  A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis , 2013, Cell Death and Differentiation.

[43]  Taiping Zhang,et al.  NOP14 promotes proliferation and metastasis of pancreatic cancer cells. , 2012, Cancer letters.

[44]  Napoleone Ferrara,et al.  Developmental and pathological angiogenesis. , 2011, Annual review of cell and developmental biology.

[45]  Emma E Vincent,et al.  Akt signalling in health and disease. , 2011, Cellular signalling.

[46]  Didier Y. R. Stainier,et al.  Molecular control of endothelial cell behaviour during blood vessel morphogenesis , 2011, Nature Reviews Molecular Cell Biology.

[47]  Nicola Elvassore,et al.  Role of YAP/TAZ in mechanotransduction , 2011, Nature.

[48]  M. Georgescu.  PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control. , 2010, Genes & cancer.

[49]  D. Green,et al.  Mitochondria and cell death: outer membrane permeabilization and beyond , 2010, Nature Reviews Molecular Cell Biology.

[50]  B. Vanhaesebroeck,et al.  The emerging mechanisms of isoform-specific PI3K signalling , 2010, Nature Reviews Molecular Cell Biology.

[51]  H. Ryoo,et al.  Expression profiling of ETS and MMP factors in VEGF‐activated endothelial cells: Role of MMP‐10 in VEGF‐induced angiogenesis , 2010, Journal of cellular physiology.

[52]  R. Gniadecki,et al.  Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes. , 2010, The Journal of investigative dermatology.

[53]  V. Haase.  The VHL tumor suppressor: master regulator of HIF. , 2009, Current pharmaceutical design.

[54]  O. Wagner,et al.  The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation , 2009, Thrombosis and Haemostasis.

[55]  Zhengyu Zha,et al.  TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition* , 2009, Journal of Biological Chemistry.

[56]  L. Ellis,et al.  VEGF-targeted therapy: mechanisms of anti-tumour activity , 2008, Nature Reviews Cancer.

[57]  K. Schulze-Osthoff,et al.  The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways , 2008, Oncogene.

[58]  Q. Zeng,et al.  A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. , 2008, Cancer research.

[59]  K. Borden,et al.  The eIF4E RNA regulon promotes the Akt signaling pathway , 2008, The Journal of cell biology.

[60]  Zhengyu Zha,et al.  TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway , 2008, Molecular and Cellular Biology.

[61]  Li Li,et al.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. , 2007, Genes & development.

[62]  R. Fariss,et al.  A novel imaging technique for experimental choroidal neovascularization. , 2006, Investigative ophthalmology & visual science.

[63]  H. Reichenbach,et al.  Antibiotics from Gliding Bacteria, LXXVI. Vioprolides: New Antifungal and Cytotoxic Peptolides from Cystobacter violaceus , 2006 .

[64]  Nahum Sonenberg,et al.  The Akt of translational control , 2005, Oncogene.

[65]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[66]  D. Redmer,et al.  Angiogenesis in the female reproductive organs: pathological implications , 2002, International journal of experimental pathology.

[67]  M. Freeman,et al.  Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells. , 2002, Cancer research.

[68]  Jongkyeong Chung,et al.  Akt: versatile mediator of cell survival and beyond. , 2002, Journal of biochemistry and molecular biology.

[69]  H. Yamaguchi,et al.  The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change , 2001, Oncogene.

[70]  D. Thiele,et al.  Novel stress-responsive genes EMG1 and NOP14 encode conserved, interacting proteins required for 40S ribosome biogenesis. , 2001, Molecular biology of the cell.

[71]  M. Yaffe,et al.  TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins , 2000, The EMBO journal.

[72]  T. Taniguchi,et al.  Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. , 2000, Science.

[73]  G. Breier,et al.  Angiogenesis in embryonic development--a review. , 2000, Placenta.

[74]  E. Levin,et al.  Extracellular Signal-regulated Protein Kinase/Jun Kinase Cross-talk Underlies Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation* , 1998, The Journal of Biological Chemistry.

[75]  J. Waltenberger,et al.  The Vascular Endothelial Growth Factor Receptor KDR Activates Multiple Signal Transduction Pathways in Porcine Aortic Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[76]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[77]  Holger Gerhardt,et al.  VEGF and Notch in tip and stalk cell selection. , 2013, Cold Spring Harbor perspectives in medicine.

[78]  Rony Seger,et al.  The MAP kinase signaling cascades: a system of hundreds of components regulates a diverse array of physiological functions. , 2010, Methods in molecular biology.

[79]  E. Crivellato,et al.  The history of the angiogenic switch concept , 2007, Leukemia.

[80]  C. Telleria,et al.  Cell death induced by serum deprivation in luteal cells involves the intrinsic pathway of apoptosis. , 2006, Reproduction.

[81]  C. Turner,et al.  JCB Article , 2001 .